loadpatents
Patent applications and USPTO patent grants for Gomez-Navarro; Jesus.The latest application filed is for "anti-ctla-4 and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment".
Patent | Date |
---|---|
Anti-ctla-4 And Cpg-motif-containing Synthetic Oligodeoxynucleotide Combination Therapy For Cancer Treatment App 20120003179 - READETT; David Robert John ;   et al. | 2012-01-05 |
Anti-Ctla-4 Antibody and Cpg-Motif-Containing Synthetic Oligodeoxynucleotide Combination Therapy for Cancer Treatment App 20090117132 - Readett; David Robert John ;   et al. | 2009-05-07 |
Anti-CTLA4 Antibody and Indolinone Combination Therapy for Treatment of Cancer App 20090074787 - Gomez-Navarro; Jesus ;   et al. | 2009-03-19 |
Therapy of Prostate Cancer With Ctla-4 Antibodies and Hormonal Therapy App 20080279865 - Gomez-Navarro; Jesus | 2008-11-13 |
Uses of anti-CTLA-4 antibodies App 20050226875 - Gomez-Navarro, Jesus ;   et al. | 2005-10-13 |
Uses of anti-insulin-like growth factor 1 receptor antibodies App 20040202651 - Cohen, Bruce D. ;   et al. | 2004-10-14 |
Adenoviral Vector Encoding Pro-apoptotic Bax Gene And Uses Thereof App 20010010814 - CURIEL, DAVID T. ;   et al. | 2001-08-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.